INO
Price
$1.98
Change
+$0.02 (+1.02%)
Updated
Aug 25, 12:18 PM (EDT)
Capitalization
104.16M
KROS
Price
$15.12
Change
-$0.44 (-2.83%)
Updated
Aug 25, 12:23 PM (EDT)
Capitalization
631.98M
66 days until earnings call
Interact to see
Advertisement

INO vs KROS

Header iconINO vs KROS Comparison
Open Charts INO vs KROSBanner chart's image
Inovio Pharmaceuticals
Price$1.98
Change+$0.02 (+1.02%)
Volume$3.8K
Capitalization104.16M
Keros Therapeutics
Price$15.12
Change-$0.44 (-2.83%)
Volume$200
Capitalization631.98M
INO vs KROS Comparison Chart in %
Loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INO vs. KROS commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a Buy and KROS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (INO: $1.96 vs. KROS: $15.56)
Brand notoriety: INO: Notable vs. KROS: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 103% vs. KROS: 141%
Market capitalization -- INO: $104.16M vs. KROS: $631.98M
INO [@Biotechnology] is valued at $104.16M. KROS’s [@Biotechnology] market capitalization is $631.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whileKROS’s FA Score has 1 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • KROS’s FA Score: 1 green, 4 red.
According to our system of comparison, KROS is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 6 TA indicator(s) are bullish while KROS’s TA Score has 6 bullish TA indicator(s).

  • INO’s TA Score: 6 bullish, 4 bearish.
  • KROS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both INO and KROS are a good buy in the short-term.

Price Growth

INO (@Biotechnology) experienced а +5.38% price change this week, while KROS (@Biotechnology) price change was +7.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.99%. For the same industry, the average monthly price growth was +19.80%, and the average quarterly price growth was +30.45%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($632M) has a higher market cap than INO($104M). INO YTD gains are higher at: 10.112 vs. KROS (-1.706). KROS has higher annual earnings (EBITDA): 25.5M vs. INO (-84.73M). KROS has more cash in the bank: 690M vs. INO (47.5M). INO has less debt than KROS: INO (10.7M) vs KROS (18M). KROS has higher revenues than INO: KROS (233M) vs INO (182K).
INOKROSINO / KROS
Capitalization104M632M16%
EBITDA-84.73M25.5M-332%
Gain YTD10.112-1.706-593%
P/E RatioN/A48.63-
Revenue182K233M0%
Total Cash47.5M690M7%
Total Debt10.7M18M59%
FUNDAMENTALS RATINGS
INO: Fundamental Ratings
INO
OUTLOOK RATING
1..100
48
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INOKROS
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
79%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIMAF52.920.84
+1.61%
Linamar Corporation
IFJPY24.550.35
+1.45%
Informa Plc.
HYDI0.23N/A
N/A
Hydromer, Inc.
MIAPF10.02N/A
N/A
MINTO APT REAL ESTATE INVT TR
BLMWF0.90N/A
N/A
BluMetric Environmental, Inc.